Vern Dolinsky (@verndolinsky.bsky.social)

The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus Nature Reviews Endocrinology, Published online: 16 July 2025; doi:10.1038/s41574-025-01154-4Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk. Adjunct therapy with glucagon-like peptide 1 receptor agonists could offer benefits in this population of patients by preserving β-cell mass and function while also contributing to cardiorenal risk mitigation. https://www.nature.com/articles/s41574-025-01154-4?utm_source=bluesky&utm_medium=social&utm_campaign=nrendo